108 related articles for article (PubMed ID: 21239753)
1. Malignancies in juvenile idiopathic arthritis: a preliminary report.
Bernatsky S; Rosenberg AM; Oen KG; Duffy CM; Ramsey-Goldman R; Labrecque J; St Pierre Y; Clarke AE
J Rheumatol; 2011 Apr; 38(4):760-3. PubMed ID: 21239753
[TBL] [Abstract][Full Text] [Related]
2. Report on malignancies in the German juvenile idiopathic arthritis registry.
Horneff G; Foeldvari I; Minden K; Moebius D; Hospach T
Rheumatology (Oxford); 2011 Jan; 50(1):230-6. PubMed ID: 21148157
[TBL] [Abstract][Full Text] [Related]
3. Juvenile idiopathic arthritis and risk of cancer: a nationwide cohort study.
Simard JF; Neovius M; Hagelberg S; Askling J
Arthritis Rheum; 2010 Dec; 62(12):3776-82. PubMed ID: 20827782
[TBL] [Abstract][Full Text] [Related]
4. Risk of malignancy in children with juvenile idiopathic arthritis not treated with biologic agents.
Nordstrom BL; Mines D; Gu Y; Mercaldi C; Aquino P; Harrison MJ
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1357-64. PubMed ID: 22511558
[TBL] [Abstract][Full Text] [Related]
5. Juvenile idiopathic arthritis--current and future therapies.
Kahn P
Bull NYU Hosp Jt Dis; 2009; 67(3):291-302. PubMed ID: 19852753
[TBL] [Abstract][Full Text] [Related]
6. Juvenile idiopathic arthritis: an update.
Olson JC
WMJ; 2003; 102(7):45-50. PubMed ID: 14711024
[TBL] [Abstract][Full Text] [Related]
7. Juvenile idiopathic arthritis.
Gowdie PJ; Tse SM
Pediatr Clin North Am; 2012 Apr; 59(2):301-27. PubMed ID: 22560572
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.
Horneff G; De Bock F; Foeldvari I; Girschick HJ; Michels H; Moebius D; Schmeling H;
Ann Rheum Dis; 2009 Apr; 68(4):519-25. PubMed ID: 18413440
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study.
Saurenmann RK; Levin AV; Feldman BM; Rose JB; Laxer RM; Schneider R; Silverman ED
Arthritis Rheum; 2007 Feb; 56(2):647-57. PubMed ID: 17265500
[TBL] [Abstract][Full Text] [Related]
10. Juvenile idiopathic arthritis: a chronic pediatric musculoskeletal condition with significant orofacial manifestations.
Barr T; Carmichael NM; Sándor GK
J Can Dent Assoc; 2008 Nov; 74(9):813-21. PubMed ID: 19000466
[TBL] [Abstract][Full Text] [Related]
11. Atrophoderma and juvenile idiopathic arthritis.
Ramanan AV; Baildam EM; Judge MR
Ann Rheum Dis; 2001 Sep; 60(9):900-1. PubMed ID: 11534508
[No Abstract] [Full Text] [Related]
12. Monitoring the long-term safety of therapies for children with juvenile idiopathic arthritis: time for a consolidated patient registry.
Smith MY; Sobel RE; Wallace CA
Arthritis Care Res (Hoboken); 2010 Jun; 62(6):800-4. PubMed ID: 20535790
[No Abstract] [Full Text] [Related]
13. Juvenile idiopathic oligoarthritis: analysis of 42 cases in Jordan.
Al-Wahadneh AM; Abu-Zeid AF; Khreisat WH
East Mediterr Health J; 2007; 13(2):461-4. PubMed ID: 17684867
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register.
Prince FH; Twilt M; ten Cate R; van Rossum MA; Armbrust W; Hoppenreijs EP; van Santen-Hoeufft M; Koopman-Keemink Y; Wulffraat NM; van Suijlekom-Smit LW
Ann Rheum Dis; 2009 May; 68(5):635-41. PubMed ID: 18413443
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary haemosiderosis with juvenile idiopathic arthritis in a Malaysian child.
Wong AR; Noor AS; Rasool AH; Quah BS; Roberton D
Med J Malaysia; 2007 Oct; 62(4):352-4. PubMed ID: 18551948
[TBL] [Abstract][Full Text] [Related]
16. [Juvenile idiopathic arthritis].
Herlin T
Ugeskr Laeger; 2002 Aug; 164(34):3941-6. PubMed ID: 12212473
[TBL] [Abstract][Full Text] [Related]
17. Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series.
Nigrovic PA; Mannion M; Prince FH; Zeft A; Rabinovich CE; van Rossum MA; Cortis E; Pardeo M; Miettunen PM; Janow G; Birmingham J; Eggebeen A; Janssen E; Shulman AI; Son MB; Hong S; Jones K; Ilowite NT; Cron RQ; Higgins GC
Arthritis Rheum; 2011 Feb; 63(2):545-55. PubMed ID: 21280009
[TBL] [Abstract][Full Text] [Related]
18. Uveitis in young adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients.
Kotaniemi K; Arkela-Kautiainen M; Haapasaari J; Leirisalo-Repo M
Ann Rheum Dis; 2005 Jun; 64(6):871-4. PubMed ID: 15897307
[TBL] [Abstract][Full Text] [Related]
19. A marked decline in the incidence of renal replacement therapy for amyloidosis associated with inflammatory rheumatic diseases - data from nationwide registries in Finland.
Immonen K; Finne P; Grönhagen-Riska C; Pettersson T; Klaukka T; Kautiainen H; Hakala M
Amyloid; 2011 Mar; 18(1):25-8. PubMed ID: 21284495
[TBL] [Abstract][Full Text] [Related]
20. [Biologic agents in juvenile idiopathic arthritis].
Gomes JA
Acta Reumatol Port; 2007; 32(1):13-4. PubMed ID: 17450760
[No Abstract] [Full Text] [Related]
[Next] [New Search]
